Inari Medical to Present at the 2021 Bank of America Healthcare Conference

Rhea-AI Summary

Inari Medical, Inc. (NASDAQ: NARI) announced its participation in the 2021 Bank of America Healthcare Conference on May 13, 2021, at 8:45 a.m. ET. This commercial-stage medical device company focuses on innovative products for venous diseases. Inari has developed two FDA-cleared devices: the ClotTriever for deep vein thrombosis and the FlowTriever for pulmonary embolism. Both systems are designed to effectively remove large clots without the need for thrombolytic drugs, enhancing patient outcomes in treating venous thromboembolism.

IRVINE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will present at the 2021 Bank of America Healthcare Conference on Thursday, May 13, 2021 at 8:45 a.m. Eastern Time.

About Inari Medical, Inc.
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.

Investor Contact:
Westwicke Partners
Caroline Corner
Phone +1-415-202-5678
caroline.corner@westwicke.com

FAQ

What will Inari Medical present at the Bank of America Healthcare Conference on May 13, 2021?

Inari Medical will present its innovative medical device solutions for treating venous diseases.

What time is Inari Medical's presentation at the Bank of America Healthcare Conference?

Inari Medical's presentation is scheduled for 8:45 a.m. Eastern Time.

What products does Inari Medical offer for venous diseases?

Inari Medical offers the ClotTriever for deep vein thrombosis and the FlowTriever for pulmonary embolism.

Are Inari Medical's devices approved by the FDA?

Yes, both the ClotTriever and FlowTriever devices are 510(k)-cleared by the FDA.

What conditions do Inari Medical's devices treat?

The devices treat venous thromboembolism, including deep vein thrombosis and pulmonary embolism.